Source: Biofortuna Blog

Biofortuna Blog Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day

Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day Biofortuna Limited (Deeside, UK), the specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has invested in an additional Lyo bead manufacturing line in response to increasing customer demand for lyophilized diagnostic tests. The new, fullyRead moreThe post Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day appeared first on Biofortuna.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Nick Ash's photo - CEO of Biofortuna

CEO

Nick Ash

CEO Approval Rating

90/100

Read more